Skip to main content
  • Main menu
  • User menu
  • Search
  • English ▼
    • English
    • Afrikaans
    • Albanian
    • Amharic
    • Arabic
    • Armenian
    • Azerbaijani
    • Basque
    • Belarusian
    • Bengali
    • Bosnian
    • Bulgarian
    • Catalan
    • Cebuano
    • Chichewa
    • Chinese (Simplified)
    • Chinese (Traditional)
    • Corsican
    • Croatian
    • Czech
    • Danish
    • Dutch
    • Esperanto
    • Estonian
    • Filipino
    • Finnish
    • French
    • Frisian
    • Galician
    • Georgian
    • German
    • Greek
    • Gujarati
    • Haitian Creole
    • Hausa
    • Hawaiian
    • Hebrew
    • Hindi
    • Hmong
    • Hungarian
    • Icelandic
    • Igbo
    • Indonesian
    • Irish
    • Italian
    • Japanese
    • Javanese
    • Kannada
    • Kazakh
    • Khmer
    • Korean
    • Kurdish (Kurmanji)
    • Kyrgyz
    • Lao
    • Latin
    • Latvian
    • Lithuanian
    • Luxembourgish
    • Macedonian
    • Malagasy
    • Malay
    • Malayalam
    • Maltese
    • Maori
    • Marathi
    • Mongolian
    • Myanmar (Burmese)
    • Nepali
    • Norwegian
    • Pashto
    • Persian
    • Polish
    • Portuguese
    • Punjabi
    • Romanian
    • Russian
    • Samoan
    • Scottish Gaelic
    • Serbian
    • Sesotho
    • Shona
    • Sindhi
    • Sinhala
    • Slovak
    • Slovenian
    • Somali
    • Spanish
    • Sudanese
    • Swahili
    • Swedish
    • Tajik
    • Tamil
    • Telugu
    • Thai
    • Turkish
    • Ukrainian
    • Urdu
    • Uzbek
    • Vietnamese
    • Welsh
    • Xhosa
    • Yiddish
    • Yoruba
    • Zulu

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

English ▼
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scottish Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sudanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleTeaching Case Study

Cervical Ganglioneuroblastoma Diagnosed by 68Ga-DOTATOC PET/CT in a Child with Opsoclonus Myoclonus Syndrome

Kusai Al-Muqbel, Hamza Alardah, Ruba Al-Smadi, Sohaib Al-Khatib and Raya Abughanmi
Journal of Nuclear Medicine Technology December 2023, 51 (4) 337-338; DOI: https://doi.org/10.2967/jnmt.123.265776
Kusai Al-Muqbel
1Department of Radiology and Nuclear Medicine, Jordan University of Science and Technology, Irbid, Jordan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hamza Alardah
1Department of Radiology and Nuclear Medicine, Jordan University of Science and Technology, Irbid, Jordan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruba Al-Smadi
1Department of Radiology and Nuclear Medicine, Jordan University of Science and Technology, Irbid, Jordan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sohaib Al-Khatib
2Department of Pathology, Jordan University of Science and Technology, Irbid, Jordan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raya Abughanmi
3Department of Neurosurgery, Jordan University of Science and Technology, Irbid, Jordan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

We performed a 68Ga-DOTATOC PET/CT scan on a 25-mo-old female patient who presented with opsoclonus myoclonus ataxia syndrome and had negative initial anatomic imaging. The scan showed a somatostatin receptor-overexpressing cervical tumor in favor of a cervical neuroendocrine tumor, with subsequent histopathologic findings of ganglioneuroblastoma.

  • ganglioneuroblastoma
  • 68Ga-DOTATOC PET/CT
  • opsoclonus myoclonus syndrome

Neuroblastic tumors have been found to develop anywhere along the sympathetic nervous chain and are divided into 3 histologic categories—ganglioneuroma, ganglioneuroblastoma, and neuroblastoma—ranging from mature to immature tumors (1). The median age at diagnosis is 17 mo (2,3). Ganglioneuroblastomas account for 20% of neuroblastic tumors (4). Ganglioneuroblastomas arising from the neck are exceptionally rare (5).

Opsoclonus myoclonus ataxia syndrome (OMAS) is a rare neuroinflammatory disorder with multiple etiologies, and the neural-crest paraneoplastic etiology is the most common (6).

It was found that 68Ga-DOTA-peptide PET/CT is the imaging modality of choice for well-differentiated neuroendocrine tumors because of its ability to locate the primary lesion and identify the extent of disease (7).

In the literature, we found a limited number of cervical ganglioneuroblastoma cases (only 16 cases) (5). We were unable to locate any case in which 68Ga-DOTA-peptide PET/CT screening was used to diagnose cervical ganglioneuroblastoma. The objective of this case report is to demonstrate the value of 68Ga-DOTATOC PET/CT in the diagnosis of cervical ganglioneuroblastoma while screening for clinically suspected neuroblastic tumors in a child who presented with OMAS. Institutional review board approval was waived for this case.

CASE REPORT

The pediatric unit referred a 25-mo-old girl with OMAS for a 68Ga-DOTATOC PET/CT scan to screen for a potential neuroblastic tumor. The patient first underwent a contrast-enhanced torso CT scan, which was reported to be unremarkable.

A 68Ga-DOTATOC PET/CT scan was performed afterward, revealing a tracer-avid soft-tissue mass in the right upper cervical region that was compatible with a somatostatin receptor-overexpressing tumor, in favor of a cervical neuroendocrine tumor. In addition, the scan revealed a tracer-avid enlarged right upper cervical lymph node suggestive of metastatic lymphadenopathy (Fig. 1). The scan was negative for tracer-avid distant metastases. A second look at the previously performed CT scan confirmed that there was a slightly enhanced soft-tissue mass in the right jugulodigastric region (Fig. 2). Neck MRI showed a well-defined heterogeneous soft-tissue mass measuring 1 × 2.1 × 2.7 cm that had high T2 and low T1 signal intensities and was enhanced on the postcontrast T1 sequence. The mass extended from the skull base to the level of the C2 vertebra, with an extension into the right retropharyngeal space and partial encasement of the right internal carotid artery (Fig. 3). Also, the neck MRI revealed pathologic upper cervical lymph nodes.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

68Ga-DOTATOC PET/CT images (PET maximum-intensity projection, A; axial view, B; coronal view, C) showing tracer-avid right upper cervical mass.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

Contrast-enhanced CT images (coronal view, A; axial view, B) showing slightly enhanced soft-tissue mass in jugulodigastric region (arrow).

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

Neck MRI showing right upper cervical mass (arrows) that is low signal on T1 sequence (coronal view, A), high signal on T2 sequence (coronal view, B), and enhanced on postcontrast T1 sequence (axial views, C and D).

Partial surgical resection was performed. Histopathology showed a nodular subtype of ganglioneuroblastoma (Fig. 4).

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

(A and B) Histopathology showing nodules composed of stroma-poor islands of primitive cells with fibrillary neuropil matrix. (C) Synaptophysin staining in tumor cells. (D) Reticulin stain highlights nested pattern.

DISCUSSION

Our patient presented with OMAS, which is an immune-mediated condition that may be paraneoplastic in the context of neuroblastoma. Peripheral neuroblastic tumors are found in 50% of children with OMAS. The most common tumor type is neuroblastoma (73%), followed by ganglioneuroblastoma (22%) and ganglioneuroma (4%) (8). Approximately 5% of peripheral neuroblastic tumors occur in the cervical region (5).

To our knowledge, this is the first case of cervical ganglioneuroblastoma that presented as paraneoplastic OMAS and was diagnosed by a 68Ga-DOTATOC PET/CT scan.

Our case demonstrates the great value of 68Ga-DOTA-peptide PET/CT scanning in screening for clinically suspected neuroblastic tumors in children, as these tumors commonly overexpress somatostatin receptors (7). Tracers currently in clinical use are 68Ga-DOTATOC, 68Ga-DOTATATE, and 68Ga-DOTANOC with high sensitivity (93%–96%) and high specificity (85%–100%) (9).

Our case is added to the 16 cases of cervical ganglioneuroblastoma reported in the literature. None of these 16 was diagnosed by 68Ga-DOTA-peptide PET/CT scanning.

CONCLUSION

We reported a rare case of cervical ganglioneuroblastoma manifested clinically as OMAS and diagnosed by a 68Ga-DOTATOC PET/CT scan of a 25-mo-old child.

DISCLOSURE

No potential conflict of interest relevant to this article was reported.

Footnotes

  • Published online Aug. 16, 2023.

REFERENCES

  1. 1.↵
    1. Jackson JR,
    2. Tran HC,
    3. Stein JE,
    4. et al
    . The clinical management and outcomes of cervical neuroblastic tumors. J Surg Res. 2016;204:109–113.
    OpenUrlGoogle Scholar
  2. 2.↵
    1. Taran K,
    2. Owecka A,
    3. Kobos J
    . Prognostic importance of cyclin E1 expression in neuroblastic tumors in children. Pol J Pathol. 2013;64:149–152.
    OpenUrlGoogle Scholar
  3. 3.↵
    1. Godkhindi VM,
    2. Basade MM,
    3. Khan K,
    4. Thorat K
    . Adult neuroblastoma: case report and literature review. J Clin Diagn Res. 2016;10:ED01–ED02.
    OpenUrlGoogle Scholar
  4. 4.↵
    1. Ma R,
    2. Wang Y,
    3. He W
    . Primary orbital ganglioneuroblastoma: a case report. Open Med (Wars). 2021;16:1076–1081.
    OpenUrlGoogle Scholar
  5. 5.↵
    1. Zeng Z,
    2. Liu J,
    3. Xu S,
    4. Qin G
    . Ganglioneuroblastoma in the retropharyngeal space: a case report and literature review. Ear Nose Throat J. 2022;9:1455613221101941.
    OpenUrlGoogle Scholar
  6. 6.↵
    1. Yıldırım M,
    2. Öncel İ,
    3. Bektaş Ö,
    4. et al
    . Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome. Eur J Paediatr Neurol. 2022;41:19–26.
    OpenUrlGoogle Scholar
  7. 7.↵
    1. Ambrosini V,
    2. Zanoni L,
    3. Filice A,
    4. et al
    . Radiolabeled somatostatin analogues for diagnosis and treatment of neuroendocrine tumors. Cancers (Basel). 2022;14:1055.
    OpenUrlGoogle Scholar
  8. 8.↵
    1. Rossor T,
    2. Yeh EA,
    3. Khakoo Y,
    4. et al
    . Diagnosis and management of opsoclonus-myoclonus-ataxia syndrome in children: an international perspective. Neurol Neuroimmunol Neuroinflamm. 2022;9:e1153.
    OpenUrlAbstract/FREE Full TextGoogle Scholar
  9. 9.↵
    1. Pauwels E,
    2. Cleeren F,
    3. Bormans G,
    4. Deroose CM
    . Somatostatin receptor PET ligands: the next generation for clinical practice. Am J Nucl Med Mol Imaging. 2018;8:311–331.
    OpenUrlGoogle Scholar
  • Received for publication April 5, 2023.
  • Revision received July 6, 2023.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 51 (4)
Journal of Nuclear Medicine Technology
Vol. 51, Issue 4
December 1, 2023
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Email Article
Citation Tools
Share
Cervical Ganglioneuroblastoma Diagnosed by 68Ga-DOTATOC PET/CT in a Child with Opsoclonus Myoclonus Syndrome
Kusai Al-Muqbel, Hamza Alardah, Ruba Al-Smadi, Sohaib Al-Khatib, Raya Abughanmi
Journal of Nuclear Medicine Technology Dec 2023, 51 (4) 337-338; DOI: 10.2967/jnmt.123.265776
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
Bookmark this article

Jump to section

  • Article
    • Abstract
    • CASE REPORT
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work Better
  • Google Scholar

More in this TOC Section

  • Uterine Metastasis Presenting as Abnormal Uterine Bleeding in a Case of Primary Breast Cancer Identified on 18F-FDG PET/CT
  • Differentiation of Discordant Lesions on Dual-Tracer PET/CT (68Ga-PSMA-11 and 18F-FDG) in Prostate Carcinoma: Diagnosis of Second Primary Malignancies
  • Crafting a Compelling Abstract That Gets Accepted
Show more Teaching Case Study

Similar Articles

Keywords

  • ganglioneuroblastoma
  • 68Ga-DOTATOC PET/CT
  • opsoclonus myoclonus syndrome
SNMMI

© 2025 SNMMI

Powered by HighWire
Alerts for this Article
Sign In to Email Alerts with your Email Address
Email this Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cervical Ganglioneuroblastoma Diagnosed by 68Ga-DOTATOC PET/CT in a Child with Opsoclonus Myoclonus Syndrome
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Cervical Ganglioneuroblastoma Diagnosed by 68Ga-DOTATOC PET/CT in a Child with Opsoclonus Myoclonus Syndrome
Kusai Al-Muqbel, Hamza Alardah, Ruba Al-Smadi, Sohaib Al-Khatib, Raya Abughanmi
Journal of Nuclear Medicine Technology Dec 2023, 51 (4) 337-338; DOI: 10.2967/jnmt.123.265776

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

We use cookies on this site to enhance your user experience

By clicking any link on this page you are giving your consent for us to set cookies.